Seeking Alpha

Elan Corp. plc (ELN)

()

News & PR
Market Currents

Buzz
Twitter: ELN

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

This Week's Failed Trials, Missed Targets in Biotech

Dec 20 • The Burrill Report • 1 Comment
Report from Europe: Stocks Recovering After Data Points to Dovish Fed

Dec 16 • The Mole • 1 Comment
Report from Europe: Theme Du Jour -- Sovereign Credit Risk

Dec 15 • The Mole • 3 Comments
Report from Europe: Dubai Out -- December In

Dec 1 • The Mole • Comment!
Thursday Options Recap

Nov 12 • Frederic Ruffy • 1 Comment
October Overview: The Goblins Came Home to Roost

Nov 2 • Philip Davis • Comment!
19 'Babies with Bathwater' and 1 'Dog with Fleas' Stocks for the Week

Oct 26 • J Clinton Hill • 9 Comments
Friday Options Recap

Oct 23 • Frederic Ruffy • 4 Comments
Report from Europe: Traders are Buying the Earnings Story

Oct 23 • The Mole • 2 Comments
Report from Europe: A Grounded Boeing to Drag Down the Dow?

Oct 21 • The Mole • 7 Comments
Wall Street Breakfast: Must-Know News

Oct 21 • SA Editor Eli Hoffmann • 7 Comments
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • 1 Comment
Report from Europe: Waiting for Earnings-Fest

Oct 13 • The Mole • Comment!
Report from Europe: See-Sawing on Mixed Data

Sep 29 • The Mole • 1 Comment
Report from Europe: Quadruple Witching Equals Volatility

Sep 18 • The Mole • 1 Comment
Elan Pays Price for Secret J&J Deal

Sep 15 • EP Vantage • 3 Comments
Wall Street Breakfast: Must-Know News

Sep 15 • SA Editors • 11 Comments
Closing Update: Stocks Manage Narrowly Higher Finish

Sep 14 • Midnight Trader • 3 Comments
Wall Street Breakfast: Must-Know News

Sep 14 • SA Editor Rachael Granby • 31 Comments
Novartis: Powering into the Multiple Sclerosis Market

Sep 8 • Richard Sater • 3 Comments
Friday Options Recap

Sep 4 • Frederic Ruffy • 2 Comments
Report from Europe for Friday, Sept. 4

Sep 4 • The Mole • 13 Comments
Wall Street Breakfast: Must-Know News

Sep 4 • SA Editor Rachael Granby • 11 Comments
Thursday Options Recap

Sep 3 • Frederic Ruffy • Comment!
PDL BioPharma: High Dividend Biotech Stock

Aug 17 • Double Dividend Stocks • 5 Comments
Elan / Johnson & Johnson Deal Going Through More Twists and Turns

Aug 8 • EP Vantage • 1 Comment
Preview from Europe: 'Earnings' May Impress, But What Happened to Revenue?

Jul 22 • The Mole • 5 Comments
Elan's Tysabri Option with J&J Could Shift Balance of Power at Biogen Idec

Jul 21 • EP Vantage • Comment!
Wall Street Breakfast: Must-Know News

Jul 21 • SA Editor Rachael Granby • 10 Comments
Preview from Europe: Onward and Upward for Equities

Jul 21 • The Mole • 1 Comment
Hoping Against Hope for Wyeth / Elan Alzheimer Dug

Jul 21 • Derek Lowe • 2 Comments
Preview from Europe: When Celebrity Economists Move Markets

Jul 17 • The Mole • 4 Comments
Shares of HGSI Up Big in Anticipation of Clinical Trials Update

Jul 16 • M. E. Garza • 1 Comment
Preview from Europe: Stocks Sent Skyward as Risk Appetite Returns

Jul 16 • The Mole • 3 Comments
Preview from Europe: Banks Up on Expectation of Goldman Earnings

Jul 14 • The Mole • 7 Comments
BioMS: Hype or Hope?

Jul 13 • Richard Sater • 14 Comments
Elan Corporation: Shares Seem Undervalued

Jul 10 • Michael Catalin Vlaicu • 5 Comments
Dealmaking Sweeps the Biotech Sector

Jul 5 • The Burrill Report • Comment!
Preview from Europe: Green Shoots Doused with Herbicide

Jul 3 • The Mole • 3 Comments
Big Win for J&J with Elan Deal

Jul 3 • David Van Knapp • 1 Comment
J&J Comes Riding to Elan's Rescue

Jul 3 • EP Vantage • 1 Comment

Elan Corp. plc (ELN)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers